|
1
|
Dancik GM and Theodorescu D:
Pharmacogenomics in bladder cancer. Urol Oncol. 32:16–22. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ploussard G, Shariat SF, Dragomir A, Kluth
LA, Xylinas E, Masson-Lecomte A, Rieken M, Rink M, Matsumoto K,
Kikuchi E, et al: Conditional survival after radical cystectomy for
bladder cancer: Evidence for a patient changing risk profile over
time. Eur Urol. 66:361–370. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gonzalez DM and Medici D: Signaling
mechanisms of the epithelial-mesenchymal transition. Sci Signal.
7:re82014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yun SJ and Kim WJ: Role of the
epithelial-mesenchymal transition in bladder cancer: From prognosis
to therapeutic target. Korean J Urol. 54:645–650. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Autuoro JM, Pirnie SP and Carmichael GG:
Long noncoding RNAs in imprinting and X chromosome inactivation.
Biomolecules. 4:76–100. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Caley DP, Pink RC, Trujillano D and Carter
DR: Long noncoding RNAs, chromatin, and development. Scientific
World Journal. 10:90–102. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nagano T and Fraser P: No-nonsense
functions for long noncoding RNAs. Cell. 145:178–181. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yin DD, Liu ZJ, Zhang E, Kong R, Zhang ZH
and Guo RH: Decreased expression of long noncoding RNA MEG3 affects
cell proliferation and predicts a poor prognosis in patients with
colorectal cancer. Tumour Biol. 36:4851–4859. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang Q, Su M, Lu G and Wang J: The
complexity of bladder cancer: Long noncoding RNAs are on the stage.
Mol Cancer. 12:1012013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zheng X, Hu H and Li S: High expression of
lncRNA PVT1 promotes invasion by inducing epithelial-to-mesenchymal
transition in esophageal cancer. Oncol Lett. 12:2357–2362.
2016.PubMed/NCBI
|
|
11
|
Lu M, Liu Z, Li B, Wang G, Li D and Zhu Y:
The high expression of long non-coding RNA PANDAR indicates a poor
prognosis for colorectal cancer and promotes metastasis by EMT
pathway. J Cancer Res Clin Oncol. 143:71–81. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cesana M, Cacchiarelli D, Legnini I,
Santini T, Sthandier O, Chinappi M, Tramontano A and Bozzoni I: A
long noncoding RNA controls muscle differentiation by functioning
as a competing endogenous RNA. Cell. 147:358–369. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dey BK, Pfeifer K and Dutta A: The H19
long noncoding RNA gives rise to microRNAs miR-675-3p and
miR-675-5p to promote skeletal muscle differentiation and
regeneration. Genes Dev. 28:491–501. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kallen AN, Zhou XB, Xu J, Qiao C, Ma J,
Yan L, Lu L, Liu C, Yi JS, Zhang H, et al: The imprinted H19 lncRNA
antagonizes let-7 microRNAs. Mol Cell. 52:101–112. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liang WC, Fu WM, Wong CW, Wang Y, Wang WM,
Hu GX, Zhang L, Xiao LJ, Wan DC, Zhang JF and Waye MM: The lncRNA
H19 promotes epithelial to mesenchymal transition by functioning as
miRNA sponges in colorectal cancer. Oncotarget. 6:22513–22525.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang XS, Zhang Z, Wang HC, Cai JL, Xu QW,
Li MQ, Chen YC, Qian XP, Lu TJ, Yu LZ, et al: Rapid identification
of UCA1 as a very sensitive and specific unique marker for human
bladder carcinoma. Clin Cancer Res. 12:4851–4858. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Huang J, Zhou N, Watabe K, Lu Z, Wu F, Xu
M and Mo YY: Long non-coding RNA UCA1 promotes breast tumor growth
by suppression of p27 (Kip1). Cell Death Dis. 5:e10082014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen P, Wan D, Zheng D, Zheng Q, Wu F and
Zhi Q: Long non-coding RNA UCA1 promotes the tumorigenesis in
pancreatic cancer. Biomed Pharmacother. 83:1220–1226. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zheng Q, Wu F, Dai WY, Zheng DC, Zheng C,
Ye H, Zhou B, Chen JJ and Chen P: Aberrant expression of UCA1 in
gastric cancer and its clinical significance. Clin Transl Oncol.
17:640–646. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ni B, Yu X, Guo X, Fan X, Yang Z, Wu P,
Yuan Z, Deng Y, Wang J, Chen D and Wang L: Increased urothelial
cancer associated 1 is associated with tumor proliferation and
metastasis and predicts poor prognosis in colorectal cancer. Int J
Oncol. 47:1329–1338. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang HM, Lu JH, Chen WY and Gu AQ:
Upregulated lncRNA-UCA1 contributes to progression of lung cancer
and is closely related to clinical diagnosis as a predictive
biomarker in plasma. Int J Clin Exp Med. 8:11824–11830.
2015.PubMed/NCBI
|
|
22
|
He A, Hu R, Chen Z, Liao X, Li J, Wang D,
Lv Z, Liu Y, Wang F and Mei H: Role of long noncoding RNA UCA1 as a
common molecular marker for lymph node metastasis and prognosis in
various cancers: A meta-analysis. Oncotarget. 8:1937–1943.
2017.PubMed/NCBI
|
|
23
|
Xiao C, Wu CH and Hu HZ: LncRNA UCA1
promotes epithelial-mesenchymal transition (EMT) of breast cancer
cells via enhancing Wnt/beta-catenin signaling pathway. Eur Rev Med
Pharmacol Sci. 20:2819–2824. 2016.PubMed/NCBI
|
|
24
|
Xue M, Pang H, Li X, Li H, Pan J and Chen
W: Long non-coding RNA urothelial cancer-associated 1 promotes
bladder cancer cell migration and invasion by way of the
hsa-miR-145-ZEB1/2-FSCN1 pathway. Cancer Sci. 107:18–27. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang W, Jiang H, Zhu H, Zhang H, Gong J,
Zhang L and Ding Q: Overexpression of high mobility group box 1 and
2 is associated with the progression and angiogenesis of human
bladder carcinoma. Oncol Lett. 5:884–888. 2013.PubMed/NCBI
|
|
26
|
Yang GL, Zhang LH, Bo JJ, Huo XJ, Chen HG,
Cao M, Liu DM and Huang YR: Huang, Increased expression of HMGB1 is
associated with poor prognosis in human bladder cancer. J Surg
Oncol. 106:57–61. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chang BP, Wang DS, Xing JW, Yang SH, Chu Q
and Yu SY: miR-200c inhibits metastasis of breast cancer cells by
targeting HMGB1. J Huazhong Univ Sci Technolog Med Sci. 34:201–206.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen YC, Statt S, Wu R, Chang HT, Liao JW,
Wang CN, Shyu WC and Lee CC: High mobility group box 1-induced
epithelial mesenchymal transition in human airway epithelial cells.
Sci Rep. 6:188152016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cheng M, Liu H, Zhang D, Liu Y, Wang C,
Liu F and Chen J: HMGB1 enhances the AGE-induced expression of CTGF
and TGF-β via RAGE-dependent signaling in renal tubular epithelial
cells. Am J Nephrol. 41:257–266. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lynch J, Nolan S, Slattery C, Feighery R,
Ryan MP and McMorrow T: High-mobility group box protein 1: A novel
mediator of inflammatory-induced renal epithelial-mesenchymal
transition. Am J Nephrol. 32:590–602. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhu L, Li X, Chen Y, Fang J and Ge Z:
High-mobility group box 1: A novel inducer of the
epithelial-mesenchymal transition in colorectal carcinoma. Cancer
Lett. 357:527–534. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Huang Z, Zhong Z, Zhang L, Wang X, Xu R,
Zhu L, Wang Z, Hu S and Zhao X: Down-regulation of HMGB1 expression
by shRNA constructs inhibits the bioactivity of urothelial
carcinoma cell lines via the NF-κB pathway. Sci Rep. 5:128072015.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liao H, Xiao Y, Hu Y, Xiao Y, Yin Z and
Liu L: Suppression of cellular proliferation and invasion by HMGB1
knockdown in bladder urothelial carcinoma cells. Oncol Res.
22:235–245. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lin T, Dong W, Huang J, Pan Q, Fan X,
Zhang C and Huang L: MicroRNA-143 as a tumor suppressor for bladder
cancer. J Urol. 181:1372–1380. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang F, Li X, Xie X, Zhao L and Chen W:
UCA1, a non-protein-coding RNA up-regulated in bladder carcinoma
and embryo, influencing cell growth and promoting invasion. FEBS
Lett. 582:1919–1927. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Xue M, Li X, Li Z and Chen W: Urothelial
carcinoma associated 1 is a hypoxia-inducible factor-1α-targeted
long noncoding RNA that enhances hypoxic bladder cancer cell
proliferation, migration, and invasion. Tumour Biol. 35:6901–6912.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Vella MC, Reinert K and Slack FJ:
Architecture of a validated microRNA: Target interaction. Chem
Biol. 11:1619–1623. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yanai H, Ban T, Wang Z, Choi MK, Kawamura
T, Negishi H, Nakasato M, Lu Y, Hangai S, Koshiba R, et al: HMGB
proteins function as universal sentinels for nucleic-acid-mediated
innate immune responses. Nature. 462:99–103. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Bonaldi T, Talamo F, Scaffidi P, Ferrera
D, Porto A, Bachi A, Rubartelli A, Agresti A and Bianchi ME:
Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect
it towards secretion. EMBO J. 22:5551–5560. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Mosevitsky MI, Novitskaya VA, Iogannsen MG
and Zabezhinsky MA: Tissue specificity of nucleo-cytoplasmic
distribution of HMG1 and HMG2 proteins and their probable
functions. Eur J Biochem. 185:303–310. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Bucci LR, Brock WA and Meistrich ML:
Heterogeneity of high-mobility-group protein 2. Enrichment of a
rapidly migrating form in testis. Biochem J. 229:233–240. 1985.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Moleri S, Cappellano G, Gaudenzi G,
Cermenati S, Cotelli F, Horner DS and Beltrame M: The HMGB protein
gene family in zebrafish: Evolution and embryonic expression
patterns. Gene Expr Patterns. 11:3–11. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wei Y, Sun Q, Zhao L, Wu J, Chen X, Wang
Y, Zang W and Zhao G: LncRNA UCA1-miR-507-FOXM1 axis is involved in
cell proliferation, invasion and G0/G1 cell cycle arrest in
melanoma. Med Oncol. 33:882016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Li HJ, Li X, Pang H, Pan JJ, Xie XJ and
Chen W: Long non-coding RNA UCA1 promotes glutamine metabolism by
targeting miR-16 in human bladder cancer. Jpn J Clin Oncol.
45:1055–1063. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wang F, Ying HQ, He BS, Pan YQ, Deng QW,
Sun HL, Chen J, Liu X and Wang SK: Upregulated lncRNA-UCA1
contributes to progression of hepatocellular carcinoma through
inhibition of miR-216b and activation of FGFR1/ERK signaling
pathway. Oncotarget. 6:7899–7917. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Chiou GY, Cherng JY, Hsu HS, Wang ML, Tsai
CM, Lu KH, Chien Y, Hung SC, Chen YW, Wong CI, et al: Cationic
polyurethanes-short branch PEI-mediated delivery of Mir145
inhibited epithelial-mesenchymal transdifferentiation and cancer
stem-like properties and in lung adenocarcinoma. J Control Release.
159:240–250. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Ling DJ, Chen ZS, Zhang YD, Liao QD, Feng
JX, Zhang XY and Shi TS: MicroRNA-145 inhibits lung cancer cell
metastasis. Mol Med Rep. 11:3108–3114. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Ren D, Wang M, Guo W, Zhao X, Tu X, Huang
S, Zou X and Peng X: Wild-type p53 suppresses the
epithelial-mesenchymal transition and stemness in PC-3 prostate
cancer cells by modulating miR-145. Int J Oncol. 42:1473–1481.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Yan Y, Wu J, Wu M, Xia Y, Tang W and Liao
Z: MiR-143 suppresses the epithelial-mesenchymal transition of
spinal glioblastoma through down-regulation of ERK5. Oncotarget.
2016.(Epub ahead of print). View Article : Google Scholar
|
|
51
|
Liu J, Mao Y, Zhang D, Hao S, Zhang Z, Li
Z and Li B: RETRACTED: MiR-143 inhibits tumor cell proliferation
and invasion by targeting STAT3 in esophageal squamous cell
carcinoma. Cancer Lett. 373:97–108. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Zhai L, Ma C, Li W, Yang S and Liu Z:
miR-143 suppresses epithelial-mesenchymal transition and inhibits
tumor growth of breast cancer through down-regulation of ERK5. Mol
Carcinog. 55:1990–2000. 2016. View Article : Google Scholar : PubMed/NCBI
|
